<DOC>
	<DOCNO>NCT02152917</DOCNO>
	<brief_summary>The total knee arthroplasty ( TKA ) well establish option treatment osteoarthritis joint . Nevertheless , still concern relate peri-operative management elderly patient , highlight complication related medical comorbidity bleeding produce surgery . One propose method decrease postoperative bleeding , accumulate favorable evidence , use tranexamic acid ( TA ) . Several study ( include prospective randomize trial placebo group ) show excellent result TA intravenous administration TKA , reduce amount bleeding , drop hemoglobin need blood transfusion . Another alternative minimize bleeding use topical hemostatic agent Floseal® , compose thrombin bovine gelatin . This substance present significant benefit bleed control several area medicine , include orthopedic surgery , action yet establish TKA . The main objective evaluate amount bleeding , drop hemoglobin need blood transfusion TKA , compare use TA , Floseal® control group . The secondary objective evaluate rate adverse event study group .</brief_summary>
	<brief_title>Comparison Floseal® Tranexamic Acid Bleeding Control After Total Knee Arthroplasty</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Indication total knee arthroplasty No previous knee surgery Absence inflammatory arthritis Absence stiff knee Absence follow factor : renal failure , liver failure , severe heart failure , respiratory failure , history thromboembolic event , bleed disorder , previous stroke</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>